# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Mitochondrial disorders

Mitochondrial genetic disordersMitochondrial diseases
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 181-190 of 243 results.
Patient Registry of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS)
Status: Recruiting
Last Changed: Mar 02, 2020
First Received: Feb 24, 2014
Disease(s): Friedreich's Ataxia
Locations: Medical University Innsbruck, Department of Neurology, Innsbruck, Austria
Université Libre de Bruxelles, Bruxelles, Belgium
Hôpital Pitié Salpêtrière, Paris, France
Hôptal de Hautepierre, Department of Neurology, Strasbourg, France
University Hospital Aachen, Dept. of Neurology, Aachen, Germany
... and 8 other locations.
A Phase IIa Trial to Test Safety and Efficacy Interferon Gamma Treatment in Elevating Frataxin Levels in FRDA Patients
Status: Completed
Last Changed: Apr 21, 2017
First Received: Jan 14, 2014
Disease(s): Friedreich Ataxia
Intervention(s): gamma interferon
Locations: Policlinico Umberto I°, Rome, Italy/Rome, Italy
Interferon Gamma-1b in Friedreich Ataxia (FRDA)
Status: Completed
Last Changed: May 15, 2015
First Received: Oct 18, 2013
Disease(s): Friedreich Ataxia
Intervention(s): Interferon Gamma-1b
Locations: Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
EPI-743 in Friedreich's Ataxia Point Mutations
Status: Completed
Last Changed: Jun 29, 2016
First Received: Oct 14, 2013
Disease(s): Friedreich's Ataxia
Intervention(s): EPI-743
Locations: University of South Florida, Tampa, Florida, United States
Safety and Efficacy Study of rAAV2-ND4 Treatment of Leber Hereditary Optic Neuropathy (LHON)
Status: Completed
Last Changed: Jan 31, 2018
First Received: Dec 28, 2010
Disease(s): Leber Hereditary Optic Neuropathy
Intervention(s): rAAV2-ND4
Locations: Department of Ophthalmology ,Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
An Open-label Study of the Effects of Acetyl-L-Carnitine on Cardiovascular Outcomes in Friedreich's Ataxia
Status: Unknown status
Last Changed: Apr 12, 2016
First Received: Aug 13, 2013
Disease(s): Friedreich's Ataxia
Intervention(s): Acetyl-L-Carnitine
Locations: University of South Florida, Tampa, Florida, United States
Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia
Status: Completed
Last Changed: Dec 05, 2018
First Received: Jul 15, 2013
Disease(s): Friedreich's Ataxia
Intervention(s): VP 20629, Placebo
Locations: UCLA Medical Center, Los Angeles, California, United States
University of South Florida, Tampa, Florida, United States
Emory University, Atlanta, Georgia, United States
University of Iowa Children's Hospital, Iowa City, Iowa, United States
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
... and 1 other locations.
Early and Longitudinal Assessment of Neurodegeneration in the Brain and Spinal Cord in Friedreich's Ataxia
Status: Enrolling by invitation
Last Changed: Feb 11, 2020
First Received: Jan 28, 2013
Disease(s): Friedreich Ataxia
Locations: University of Minnesota, Minneapolis, Minnesota, United States
Safety and Efficacy of EPI-743 in Patients With Friedreich's Ataxia
Status: Completed
Last Changed: Aug 31, 2020
First Received: Nov 16, 2012
Disease(s): Friedreich's Ataxia
Intervention(s): Placebo, EPI-743 400 mg, EPI-743 200 mg
Locations: University of California Los Angeles, Los Angeles, California, United States
University of South Florida, Tampa, Florida, United States
Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
An Objective Double-blind Evaluation of Bupropion and Citalopram in an Individual With Friedreich Ataxia
Status: Completed
Last Changed: Sep 19, 2016
First Received: Oct 29, 2012
Disease(s): Friedreich Ataxia
Intervention(s): bupropion & Citalopram, Bupropion & Placebo, Placebo & Citalopram, Placebo & Placebo